BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2546255)

  • 1. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P; Bourgain R; Mencia-Huerta JM
    Semin Thromb Hemost; 1989 Apr; 15(2):184-96. PubMed ID: 2546255
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R; Kilian U
    Med Klin (Munich); 1989 Jun; 84(6):286-93. PubMed ID: 2547143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of platelet activating factor on blood platelets].
    Fu JM
    Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618
    [No Abstract]   [Full Text] [Related]  

  • 4. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of platelet activating factor in asthma].
    Ukena D; Sybrecht GW
    Dtsch Med Wochenschr; 1988 Oct; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?].
    Uhl D
    Med Monatsschr Pharm; 1989 Jun; 12(6):170-2. PubMed ID: 2544789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet activating factor].
    Deguchi K; Murashima S; Deguchi A
    Nihon Rinsho; 1987 May; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
    Hwang SB
    J Lipid Mediat; 1990; 2(3-4):123-58. PubMed ID: 1966805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent development of platelet-activating factor antagonists.
    Shen TY; Hussaini I; Hwang SB; Chang MN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
    Harper MJ; Kudolo GB; Alecozay AA; Jones MA
    Prog Clin Biol Res; 1989; 294():305-15. PubMed ID: 2542988
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin.
    Carveth HJ; Shaddy RE; Whatley RE; McIntyre TM; Prescott SM; Zimmerman GA
    Semin Thromb Hemost; 1992 Jan; 18(1):126-34. PubMed ID: 1315452
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M; Guinot P; Hosford D; Braquet PG
    Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of platelet activating factor by using mouse ontogenic technology].
    Kume K; Shimizu K; Ishii S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):572-5. PubMed ID: 9081720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet-activating factor antagonists and asthma].
    Wang YY; Li CL
    Sheng Li Ke Xue Jin Zhan; 1992 Apr; 23(2):136-40. PubMed ID: 1329195
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular biology. Inflammatory activities.
    Barnes PJ
    Nature; 1991 Jan; 349(6307):284-5. PubMed ID: 1846227
    [No Abstract]   [Full Text] [Related]  

  • 17. Hetrazepine PAF antagonists.
    Ikegami K; Meade CJ; Heuer HO; Birke F
    J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G
    Lab Invest; 1994 Apr; 70(4):435-6. PubMed ID: 8176883
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.
    Prescott SM; McIntyre TM; Zimmerman G
    J Clin Invest; 1999 Oct; 104(8):1019-20. PubMed ID: 10525039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.